HBV-IN-36

HBV-IN-36 (compound 42) is a HBV inhibior (IC50=2 μM), showing anti-HBV activity with EC50 of 0.58 μM[1].

Product Specifications

UNSPSC

12352005

Target

HBV

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/hbv-in-36.html

Solubility

10 mM in DMSO

Smiles

ClC1=C(F)C=CC(OC2=C(C3CCN(C(C4=CC=NC=C4)=O)CC3)N=CC=N2)=C1

Molecular Formula

C21H18ClFN4O2

Molecular Weight

412.84

References & Citations

[1]Detta E, et al. Structure-based Design of Novel Hepatitis B Virus Capsid Assembly Modulators. Bioorg Med Chem Lett. 2023 Sep 1;93:129412.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-06642AF647 0.1 mL

Rabbit Polyclonal TAF7L Antibody [Alexa Fluor 647]

Ask

View Details

MC200033 10 µg

E2f5 (NM_007892) Mouse Untagged Clone

Ask

View Details

MBS1281387-01 0.02 mg (E-Coli)

Recombinant Human Vitelline membrane outer layer protein 1 homolog (VMO1)

Ask

View Details

MBS1281387-02 0.1 mg (E-Coli)

Recombinant Human Vitelline membrane outer layer protein 1 homolog (VMO1)

Ask

View Details

MBS1281387-03 0.02 mg (Yeast)

Recombinant Human Vitelline membrane outer layer protein 1 homolog (VMO1)

Ask

View Details

MBS1281387-04 0.1 mg (Yeast)

Recombinant Human Vitelline membrane outer layer protein 1 homolog (VMO1)

Ask

View Details